#U.S. Contract Research Organization (CROs) Market Outlook

[researchreportinsight]

Clinical Trials Market Growth Drivers With Outlook And Opportunity Forecast To 2030

The global clinical trials market reached a valuation of USD 80.7 billion in 2023, with an expected compound annual growth rate (CAGR) of 6.49% from 2024 to 2030. A significant increase in market growth was observed in 2020 due to the COVID-19 pandemic, impacting both virtual and traditional clinical trials. Many pharmaceutical and biotech companies prioritized novel drug development in response to the pandemic, seeking to reduce the impact of COVID-19 on patient health. An example of such efforts was in 2020, when Synairgen plc partnered with Parexel for a Phase III trial evaluating Interferon-beta (IFN-beta) as a treatment for COVID-19. The market's positive growth is also influenced by rapid advancements in technology, the rising prevalence of chronic diseases, globalization in clinical trials, a push for personalized medicine, and increased demand for contract research organizations (CROs) to support research activities.

The pandemic also changed how clinical trials were conducted. Regulatory agencies like the U.S. FDA, European Medicines Agency (EMA), National Institutes of Health (NIH), and China’s National Medical Products Administration issued guidelines during COVID-19 to facilitate decentralized and virtual trials. These adaptations helped support remote methods, like telehealth and home-based patient monitoring, to continue trials despite social distancing measures. This evolving approach to research and development, driven by the urgency of finding new treatment options, led to the adoption of fast-track clinical trials. As a result, the clinical trials market is expected to continue expanding as new opportunities emerge for faster, more flexible trial designs.

Gather more insights about the market drivers, restrains and growth of the Clinical Trials Market

Government support and initiatives are also playing a crucial role in enhancing market growth potential. For instance, the World Health Organization (WHO) launched the Solidarity trial, a large-scale international clinical trial aiming to identify effective COVID-19 treatments. This trial tested multiple treatments against a standard care approach to evaluate their efficacy in combatting COVID-19. In May 2020, the WHO also initiated an international collaboration for the rapid development of multiple vaccine candidates, known as the Solidarity Vaccine Trials, to accelerate COVID-19 vaccine development.

Phase Segmentation Insights:

The Phase III segment dominated the market, capturing 53.3% of the total revenue share in 2023. Phase III trials are a significant contributor to market growth due to the high volume of participants involved. The median cost for a single Phase III trial exceeds USD 19.0 million. Phase III trials are essential for assessing drug efficacy and safety on a larger scale, requiring a substantial number of participants and often a more extended treatment duration than previous phases. According to a clinical trial logistics survey conducted by Nice Insights, 35% of Phase III trials are outsourced to CROs, a figure expected to grow as more investigational drugs progress to Phase III.

The Phase II segment is also projected to grow considerably throughout the forecast period. Phase II trials are the second most expensive stage after Phase III and typically involve two parts. The first part focuses on exploring a range of doses along with initial efficacy studies, while the second part aims to determine the optimal dose. Phase II trials are critical in oncology research, where effective dosing is paramount. According to FDA estimates, approximately 33% of investigational drugs are in Phase II trials. A significant number of oncology-related therapies and vaccines are currently in Phase II, which is helping drive the growth of this segment. The rising number of both industry-sponsored and independent clinical trials in Phase II, as well as the complex nature of these trials and the international expansion of clinical research, are factors contributing to the growth of the clinical trials market.

Overall, the clinical trials market is experiencing strong momentum driven by increasing demands for innovative medical treatments, regulatory adjustments for flexible trial processes, and significant financial investments. As the need for more efficient and effective clinical research rises, particularly in areas like oncology and infectious diseases, the market is well-positioned to see sustained growth over the coming years.

Order a free sample PDF of the Clinical Trials Market Intelligence Study, published by Grand View Research.

[health-views-updates]

Mergers and Acquisitions in the Clinical Trial Management System Industry: A Strategic Analysis

The global Clinical Trial Management System (CTMS) market revenue is set for robust growth, with its market size valued at USD 1.82 billion in 2023 and projected to reach USD 5.49 billion by 2031. This growth trajectory represents a compound annual growth rate (CAGR) of 14.8% during the forecast period from 2024 to 2031.

Clinical Trial Management Systems are essential software solutions that streamline the management, planning, and tracking of clinical trials. From study planning and tracking patient enrollment to managing data and ensuring compliance, CTMS software is a critical tool for pharmaceutical companies, contract research organizations (CROs), and healthcare institutions engaged in clinical research.

Key Drivers of Market Growth

The growth of the CTMS market can be attributed to several factors, primarily the increasing complexity of clinical trials, stringent regulatory requirements, and the need for enhanced data management solutions. As the development of new drugs and therapies becomes more intricate, organizations are increasingly seeking efficient solutions to manage the vast amounts of data generated throughout the clinical trial process.

Additionally, there is a rising emphasis on digitalization within the healthcare sector. Pharmaceutical companies and CROs are adopting digital tools to optimize workflow, reduce trial timelines, and minimize costs. This trend has been further accelerated by the COVID-19 pandemic, which highlighted the importance of remote monitoring, real-time data tracking, and efficient data management systems in ensuring continuity and compliance in clinical trials.

The surge in the number of clinical trials, particularly in the fields of oncology, immunology, and chronic disease management, is also fueling demand for advanced CTMS solutions. These systems enable researchers to manage trials more efficiently, from protocol planning and site selection to data analysis and reporting.

Get Free Sample Report: https://www.snsinsider.com/sample-request/1901

Technological Innovations

Technological advancements play a crucial role in the expansion of the CTMS market. Modern CTMS platforms are now equipped with cloud-based functionalities, artificial intelligence (AI), machine learning (ML), and data analytics capabilities, making them more powerful and user-friendly. Cloud-based CTMS solutions, in particular, offer advantages such as remote access, scalability, and seamless integration with other clinical trial software, thereby improving the overall efficiency of trial management.

AI and ML technologies are being integrated into CTMS platforms to facilitate predictive analytics, automated data collection, and real-time monitoring. These innovations enable faster decision-making, enhanced patient recruitment, and improved study outcomes, making clinical trials more effective and reducing time-to-market for new therapies.

Regional Market Insights

The CTMS market is seeing significant growth across various regions. North America currently leads the market, driven by the presence of major pharmaceutical companies, increased R&D activities, and supportive regulatory frameworks. The U.S., in particular, remains a major hub for clinical trials, contributing to the substantial demand for advanced CTMS solutions.

Meanwhile, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as a growing number of clinical trials, increased outsourcing to CROs, and rising healthcare infrastructure investments in countries like China, India, and Japan are propelling market expansion. The region’s cost-effective operational landscape and availability of a large patient pool make it an attractive destination for clinical research, driving the adoption of CTMS platforms.

Future Outlook

The future of the Clinical Trial Management System market looks promising, with continued advancements in technology set to drive growth. As the demand for more efficient, cost-effective, and faster clinical trials rises, industry players are expected to focus on enhancing their CTMS platforms with AI, cloud computing, and data analytics capabilities.

Moreover, the increasing trend towards decentralized clinical trials (DCTs) — where remote monitoring and digital tools are used to conduct trials outside traditional clinical settings — is anticipated to further boost the adoption of CTMS solutions. This shift towards digital trials underscores the need for robust, scalable, and integrated CTMS platforms that can handle the growing complexities of clinical research.

Conclusion

With a current market size of USD 1.82 billion, the Clinical Trial Management System market is poised for significant growth, reaching an estimated USD 5.49 billion by 2031. The market’s expansion, driven by technological innovations, growing clinical research activities, and the need for efficient trial management, reflects a transformative period in the field of clinical trials. As the global healthcare sector continues to evolve, CTMS solutions will play a pivotal role in ensuring streamlined, compliant, and successful clinical research.

Other Trending Reports

Surgical Tables Market Size

DNA Synthesizer Market Size

gRNA Market Size

Sequencing Market Size

[deshpandeisha]

Exploring Global AI-based Clinical Trials Solution Provider Market Growth and Size with Our Research Company

The global AI-based clinical trials solution provider market size reached USD 1.30 Billion in 2021 and is expected to register a revenue CAGR of 22% during the forecast period, according to latest analysis by Emergen Research. Increasing adoption of Artificial Intelligence (AI)-enabled digital technology is a key factor driving global AI-based clinical trials solution provider market revenue growth. Increasing use of AI-enabled digital health technologies coupled with patient support platforms is expected to improve patient engagement and retention throughout study duration as well as after study termination, which is expected to propel revenue growth of the global AI-based clinical trial solution provider market. 

AI-enabled technologies are enabling data integration and interpretation along with evolutionary modelling and pattern recognition for gathering, normalizing, analyzing, and harnessing the growing volumes of data that fuel modern therapy development. Thus, AI and advanced analytics are considered as the digital technology that can potentially improve clinical R&D productivity and clinical outcomes, and this is expected to augment growth of global AI-based clinical trials solution provider market to a significant extent.

The segmentation of the industry by type, application, classification, and geography works as an impetus towards increasing the sale figures and boosting business prospects alongside the hindrances that often restrict the industry's growth. In addition, bifurcation of the market on the basis of consumption volume, customer preference, end-user, and production capacity is explained through important resources including but not limited to charts, graphic images, and tables.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/774

The leading market contenders listed in the report are: AiCure, LLC, Unlearn.AI, Inc., BioAge Labs Inc., Antidote Technologies, Inc., Saama Technologies Inc., International Machine Business Corporation (IBM), Concentro Health AI, Deep 6 AI Inc., PathAI Inc., and Owkin Inc

The research study examines historic data from 2018 and 2020 to draw forecasts until 2030. The timeline makes the report an invaluable resource for readers, investors, and stakeholders looking for key insights in readily accessible documents with the information presented in the form of tables, charts, and graphs. To Visit Full Report & Table of Contents AI-based Clinical Trials Solution Provider Market: https://www.emergenresearch.com/industry-report/ai-based-clinical-trials-solution-provider-market

Emergen Research has segmented the global AI-based clinical trials solution provider market on the basis of clinical trial phase, therapeutic application, end-use, and region:

Clinical Trial Phase Outlook (Revenue, USD Billion; 2019–2030)

Phase-I

Phase-II

Phase-III

Therapeutic Application Outlook (Revenue, USD Billion; 2019–2030)

Cancer

Cardiovascular Disease

Neurological Disease

Metabolic Disease

Infectious Disease

Others

End-use Outlook (Revenue, USD Billion; 2019–2030)

Pharmaceuticals

Academia

Contract Research Organizations (CROs)

The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market. Get An Impressive Discount On This Report@ https://www.emergenresearch.com/request-discount/774

Regional Analysis Covers: North America (U.S., Canada) Europe (U.K., Italy, Germany, France, Rest of EU) Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC) Latin America (Chile, Brazil, Argentina, Rest of Latin America) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key reasons to buy the Global AI-based Clinical Trials Solution Provider Market report:

The latest report comprehensively studies the global AI-based Clinical Trials Solution Provider market size and provides useful inference on numerous aspects of the market, such as the current business trends, market share, product offerings, and product share.

The report offers an insightful analysis of the regional outlook of the market.

It offers a detailed account of the end-use applications of the products & services offered by this industry.

The report holistically covers the latest developments taking place in this industry. Therefore, it lists the most effective business strategies implemented by the market rivals for ideal business expansion.

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/774

[aeroautomotive]

Pharmacovigilance and Drug Safety Software Market Global Analysis and Forecasts by Solutions, Component, and Application to 2027

The “Global Pharmacovigilance and Drug Safety Software Market research report| Industry 2027 year” unveils cutting-edge market research findings. The Insight Partners is leading market research and consultation company is proud to announce the release of a comprehensive research report on the Pharmacovigilance and Drug Safety Software market. Leveraging advanced methodologies and cutting-edge technology Insight Partners has delved deep into market trends to deliver valuable insights for businesses seeking a competitive edge.

Key highlights of this market report:

Thorough Market Analysis-

Insight Partners has conducted an in-depth investigation of the Pharmacovigilance and Drug Safety Software market highlighting key drivers, challenges, and opportunities in the forecast period. Important contents analyzed in this report are key stats such as market size, market segments, revenue projections, and future market trends. This report offers subsegments information and includes information on all major countries and associations. This study further deep dives into market barriers and issues associated with cost and ROIs affecting Pharmacovigilance and Drug Safety Software market companies.

Empower Your Business| Request A Free Sample- https://www.theinsightpartners.com/sample/TIPHC00002557/

Consumer Behavior Insight

The report provides a nuanced understanding of changing consumer preferences, enabling businesses to tailor their strategies for maximum impact. It comprehensively covers key factors impacting the business with accurate future projections. Investors can make informed decisions based on unbiased market scenario coverage.

Competitive Landscape

The Insight Partners have meticulously mapped out the competitive terrain of the Pharmacovigilance and Drug Safety Software market, offering a clear picture of key market players, their market share, and potential collaborations. This section also provides insights into potential challenges companies might face in increasing competitiveness.

Technological Disruptions

This report covers insights into the role of technology in the transformation of the Pharmacovigilance and Drug Safety Software market. Covering the latest technological advancements this section attempts to guide business for Industry 4.0 transformations.

Global Market Outlook

This report offers a global and regional growth outlook for companies in the Pharmacovigilance and Drug Safety Software market. Key market players are- Veeva Systems, IQVIA Inc., Ennov, AB Cube, United Biosource LLC, ArisGlobal LLC, Sparta Systems, Oracle Corporation, Sarjen Systems Pvt. Ltd, EXTEDO, Maxapplication, Online Business Applications, Inc. . This report aims to offer an understanding of the global market situation and identify key regions for growth in the future.

Strategic Recommendations

The Insight Partners presents actionable insights to empower businesses in making informed decisions based on industry evidence. These lucrative suggestions intend to offer our clients a competitive edge over their competitors.

Pharmacovigilance and Drug Safety Software Market Segmentation

Based on Software Type of Pharmacovigilance and Drug Safety Software Market Research report:

Adverse Event Reporting Software

Drug Safety Audits Software

Issue Tracking Software

and Fully Integrated Software

Based on Delivery Mode of Pharmacovigilance and Drug Safety Software Market Research report:

On-premise

Cloud-based

Based on End User of Pharmacovigilance and Drug Safety Software Market Research report:

Pharmaceutical and Biotech Companies

Contract Research Organizations (CROs)

Business Process Outsourcing (BPO) Firms

and Pharmacovigilance Service Providers

Based on Regions:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of Latin America)

The Middle East and Africa (Turkey, GCC, Rest of the Middle East and Africa)

Rest of the World…

Talk to Our Analyst and Explore more about Customization - sales@theinsightpartners.com

To Summarize the Key Highlights of this Report:

Market Estimates | Forecast Year

Market Dynamics – Drivers, Restraints, Opportunities, and Threats

Market Segmentation – Product Types, Application, and Regional Markets

Competitive Landscape – Top Market Participants and their Business Strategies.

About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

[shital1998]

Biopharmaceutical Processing Equipment and Consumables Market - Global Opportunity Analysis and Industry Forecast (2022-2029)

Meticulous Research®– leading global market research company published a research report titled “Biopharmaceutical Processing Equipment and Consumables Market by Product Type {Filtration, Chromatography [Columns, Equipment], Disposable Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D), and End User- Forecast to 2029.”

According to this latest publication from Meticulous Research, the global biopharmaceutical processing equipment and consumables market is expected to grow at a CAGR of 10.3% to reach $70.84 billion by 2029. Initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical manufacturing plants, and growing use of single-use technologies in commercial bioproduction are the factors driving the market growth.

Biopharmaceutical Processing Equipment and Consumables Market: Future Outlook

The global biopharmaceutical processing equipment and consumables market study presents, historical market data in terms of values (2020 and 2021), estimated current data (2022), and forecasts it for 2029 –by Product Type (Filtration Systems, Chromatography Systems {Resins, Columns, & Equipment}, Bioreactors {Reusable Bioreactors, Disposable/Single-use Bioreactors}, Cell Culture Products {Cell Culture Media [Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media], [Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media], [Cell Culture Media Market, by Source-Chemically Defined Media, Natural Media], Reagents and Supplements, Cell and Cell Lines, Serum}, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Consumables and Accessories, Services), Application (Commercial Bioproduction {Vaccine Manufacturing, mAb Production, Recombinant Protein Production, Cell and Gene Therapy Production}, Research and Development), End User (Biopharmaceutical/ Biotechnology Companies, Contract Development and Manufacturing Organizations and Contract Research Organizations (CDMOs/CROs), & Academics and Research Institutes), and Geography. The study also evaluates industry competitors and analyzes their market share at global and regional levels.

Download Free Sample PDF Copy: https://www.meticulousresearch.com/download-sample-report/cp_id=4200

Scope of the Report:

Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type

 Resins

 Columns

 Equipment

 Reusable      Bioreactors

 Disposable/Single-use      Bioreactors

   Dry Powder Media

   Liquid Media

     Off-the-Shelf Media

   Custom Media

     Chemically Defined Media

   Natural Media

  (Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors)

Global Biopharmaceutical Processing Equipment and Consumables Market, by Application

 Vaccine      Manufacturing

 mAb      Production

 Recombinant      Protein Production

 Cell      and Gene Therapy Production

Global Biopharmaceutical Processing Equipment and Consumables Market, by End User

Biopharmaceutical/     Biotechnology Companies

Contract     Development and Manufacturing Organizations and Contract Research     Organizations (CDMOs/CROs)

Academics     and Research Institutes

 Biopharmaceutical Processing Equipment and Consumables Market, by Geography

 U.S.

 Canada

 Germany

 U.K.

 France

 Italy

 Spain

 Switzerland

 Rest      of Europe (RoE)

 China

 Japan

 India

 Rest      of APAC (RoAPAC)

Speak to Our Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=4200 Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2022. The technological developments in filtration technologies and accelerated developments of single-use filtration systems to meet the growing need for single-use bioprocessing systems are contributing to the largest market share.

Based on application, the market is segmented into commercial bioproduction and R&D. The commercial bioproduction segment is estimated to account for the largest share of the market in 2022, owing to the growing number of biopharmaceuticals in the clinical development and nearing patent expiry of biologics.

Based on end user, the biopharmaceutical/biotechnology companies segment is estimated to account for the largest share of the market in 2022. The largest revenue share is attributed to the growing demand for biopharmaceutical equipment for commercial bioproduction in biopharmaceutical/biotechnology companies.

Geographic Review:

This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and Middle East & Africa.

North America is estimated to command the largest share of the biopharmaceutical processing equipment and consumables market in 2022, followed by Europe and Asia-Pacific. The U.S. is estimated to be the largest shareholding market in North America in 2022. An increase in the biotechnology R&D expenditure, the emergence of infectious diseases, supportive initiatives for increasing adoption of biosimilars, and large number of biopharmaceutical companies are some of the major factors driving the demand for biopharmaceutical processing equipment and consumables in the country.

BUY NOW: https://www.meticulousresearch.com/Checkout/94239620 Key Players

The key players operating in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).

Key questions answered in the report-

Which are the high-growth market     segments in terms of product type, application, end user, and     regions/countries?

What was the historical market for     biopharmaceutical processing equipment and consumables across the globe?

What are the market forecasts and     estimates for the period 2022–2029?

What are the major drivers,     restraints, challenges, opportunities, and trends in the global market of     biopharmaceutical processing equipment and consumables?

Who are the major players in the     global biopharmaceutical processing equipment and consumables market?

How is the competitive landscape,     and who are the market leaders in the global biopharmaceutical processing     equipment and consumables market?

What are the recent developments in     the biopharmaceutical processing equipment and consumables market?

What are the different strategies     adopted by the major players in the biopharmaceutical processing equipment     and consumables market?

What are the geographical trends     and high growth regions/countries?

top 10 companies operating in Biopharmaceutical Processing Equipment And Consumables Market- https://meticulousblog.org/top-10-companies-in-biopharmaceutical-processing-equipment-and-consumables-market/

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Connect with us on Twitter- https://twitter.com/MeticulousR123

[fostermarketarch]

Contract Research Organizations Market Revenue - Due To Increase In Huge Demand In This Sector

The global Contract Research Organizations market was valued at US$ xx million in the year 2019. The market is estimated to be valued at US$ xx million in the year 2020, and is expected to reach US$ xx million by the year 2027, with an estimated CAGR of xx% during the forecast period (2021-2027). The research study also includes exhaustive information about market dynamics such as drivers, restraints, opportunities, technological advancements, future trends, supply chain analysis, patent landscape, pricing analysis, regulatory and reimbursement framework for precise market estimations and forecasts.

Additionally, the business intelligence study encompasses the COVID-19 scenario as follows:

· Long-Term, Mid-Term, and Short-Term Impact of COVID-19

· Pre- and Post-COVID-19 Scenario

· Disruptions in the Supply Chain

Get Free PDF Brochure Of This Report @ https://www.fostermarketresearch.com/product/industry/10/166/Pdf%20Brochure/

Competitive Insights

Leading and emerging companies of the global Contract Research Organizations market were identified based on their current offerings. Further, the Contract Research Organizations industry is one of the most competitive industries, with the leading players actively competing against each other to gain a greater share in the industry. Some of the major companies in the Contract Research Organizations market are: PRA Health Sciences, Cereno Scientific AB, ICON plc, IQVIA, PAREXEL, LabCorp, PPD, Syneos Health, WuXi AppTech, Medpace, Charles River, and SGS, among others.

The competitive landscape of the Contract Research Organizations industryexhibits an inclination towards emerging strategies including product launches, partnerships, collaborations and contracts, acquisitions, funding, and other developments to achieve the objectives faster.

Our reports fill up the gaps and provide you with all the detailed analysis of competitive companies involving:

· Analyzing competitive strategies and techniques

· Competitive positioning of key players

· PORTER’s and SWOT analysis for competitive risk analysis

· Competitive Share Analysis

· Financial analysis of players to determine their withstand capacity

· Analyzing their sales path and product study

For More Information Of This Report @ https://www.fostermarketresearch.com/product/industry/10/166/

Key Segments Covered in the global Contract Research Organizations market report are:

· By Service Type: (Drug Discovery, Preclinical studies, Early Phase I – Iia, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding, and Writing, Monitoring, Clinical Data Management, Bio-statistics, Site Management, Protocol Development, Biomarker Discovery)

· By Application: (Infectious Disease, Oncology, Metabolic Disorders, Cardiovascular Diseases, Central Nervous System Diseases, Immunological Disorders, Respiratory Disorders, and Others), By Size of CROs (Small Size, Medium Size, and Large Size)

· By End User (Research Institute, Pharma and Biotech Companies, and Others )

Regional Coverage:

The global Contract Research Organizations market segregates into five regions including North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America followed by Europe held the major share of the global market (in terms of value) in 2020. However, Asia-Pacific region exhibit highest CAGR (%) during the forecast period (2021-2027). Our research study further sub-divides regions into countries as follows:

· North America - the U.S. and Canada

· Europe - Germany, the U.K., France, Spain, Italy, Russia, and Rest-of-Europe

· Asia-Pacific - China, India, Japan, South Korea, Australia, ASEAN, and Rest-of-Asia-Pacific

· Latin America - Mexico, Brazil, and Rest-of-Latin America

· Middle East and Africa - Gulf Cooperation Council (GCC) Countries, South Africa, Israel, and Rest-of-Middle East and Africa

Market Dynamics:

Rapidly growing pharmaceuticals and biotechnology companies are investing in research organizations to maintain a position in the competitive space. The rising requirements for clinical trials of medical equipment, expanding capabilities of research organizations using technology, and increasing demand for outsourcing services in developing countries are prospecting the growth for the contract research organization market. Additionally, favorable regulatory environments in the developed countries in North America and the European region are providing a positive outlook for the market. The clinical development for coronavirus is positively impacting the CRO’s growth. The outsourced research has gained momentum for the development of drugs and vaccines in the COVID-19 situation. For instance, in April 2020, Covance Inc., a CRO took the clinical trials for developing a vaccine against the coronavirus.

Buy Now This Business Strategic Report To Improve Your Profits @ https://www.fostermarketresearch.com/product/buy/10/166/

About Foster Market Research:

Foster Market Research is a global market intelligence and advisory firm engaged in providing data-driven research extract from rigorous analysis, to the clients to make critical business decisions and execute them successfully. Foster connects over various distribution channels and numerous markets for great understanding of the trends and market to deliver our clients with accurate data.

Our focus is on providing market research that delivers a positive impact on your business. We work continuously to provide our clients with the most accurate analytics data and research reports without any delay so as to improve their business strategies and provide them with rich customer experience.

Contact Us:

1701 Royal Lane,

#1306, Dallas

Tx-75229

Phone: +1 469 4981929

Email: support@fostermarketresearch.com

[mrfrblogresearch02]

Drug Discovery Informatics Market Statistics, Industry Figures With Demand By Countries And Future Growth 2027

Market Highlights

The global Drug Discovery Informatics Market Share held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% over the forecast period. Factors driving market growth include impending need to curtail drug discovery and development costs, focus on drug discovery, increasing expenditure on R&D, and large prevalence of chronic diseases. According to the WHO report of 2001, chronic diseases accounted for 60% of the deaths that year. Nearly 46.4% of the deaths in 2020 will be credited to chronic diseases triggering the market demand. But setup of laboratories and high costs of informatics software can restrict the market growth.

Drug discovery plays a vital role in the life sciences, pharmaceutical, and biopharmaceutical industries. The amount of data accumulated from clinical trials and tests is vast and requires software to sift through. New approaches in drug discovery informatics for accumulating and processing information can lead to faster commoditization of drugs, medicines, and vaccines. The global drug discovery informatics market report by Market Research Future (MRFR) contains a comprehensive overview followed by pertinent factors and drawbacks for the period

Regional Analysis

Europe, Asia Pacific (APAC), the Americas, and the Middle East & Africa (MEA) are regions covered in the global drug discovery informatics market report.

The Americas dominated the global market in 2017 due to presence of prominent names such as International Business Machines, PerkinElmer Inc., and ThermoFisher Scientific Inc. Establishment of next-generation sequencing and chemical laboratories in the U.S. and Canada, boom in pharmaceutical and biopharmaceutical industries, and sophisticated healthcare infrastructure.

Europe is the second largest region and highly lucrative for the global drug discovery informatics market till 2023. This can be credited to funding allocated to research and development on drug research by governments, growth in therapeutic discovery centers, and successful activities by research and academic institutes, universities, and other prestigious centers.

APAC can be ensured to display a profitable growth rate during the forecast period due to the large geriatric population, drug delivery system packaging factory and heavy prevalence of chronic diseases. Awareness of the software, adoption of the software in pharma and biopharma companies, and a rise in clinical studies can drive the regional market growth. Lower costs, lax policies and regulations, and a spurt in clinical trials are other factors making the region lucrative for the global drug discovery informatics market.

Drug Discovery Informatics Market Segmentation:

The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.

By product, the market has been segmented into discovery informatics and development informatics.

On the basis of mode, the market has been divided into in-house informatics and outsourced informatics.

By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.

Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.

Drug Discovery Informatics Market Competitive Outlook

Few of the foremost players in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

[reportsanddata]

In-Vitro Diagnostics (IVD) Quality Control Market Revenue Trends, Company Profiles, Revenue Share Analysis, 2020–2028

A new research report titled global In-Vitro Diagnostics (IVD) Quality Control Market report published by Reports and Data provides a brief overview of the industry and gives an estimation of growth and revenue for the forecast period of 2021-2028. The report covers profiling and study of major manufacturers of the In-Vitro Diagnostics (IVD) Quality Control  market along with their sales, revenue, and market share. The report further analyzes market segments, size, trends, growth drivers, restraining factors, opportunities and challenges, cost overview, SWOT analysis, and Porter’s Five Forces Analysis. The report all includes industrial chain analysis, revenue growth, sales estimation, value chain analysis, capacity, regional market examination, and market forecast up to 2028. The report offers insightful information that will assist in gaining a market position and maximize on lucrative growth opportunities.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1508

The report provides an in-depth analysis of the key developments and innovations of the market such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report offers a comprehensive assessment of key players in the market along with their global position, financial standing, business expansion plans, production and manufacturing capacity, and strategic alliances.

Key players in the market include

Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Randox Laboratories Ltd., Technopath Clinical Diagnostics, Fortress Diagnostics, Roche Diagnostics, Bio-Techne Corporation, Danaher Corporation, SeraCare Life Sciences Inc., Ortho-Clinical Diagnostics, Inc., Sysmex Corporation, and Helena Laboratories.

Furthermore, the report segments In-Vitro Diagnostics (IVD) Quality Control  market on the basis of key product types and applications and provides details about the revenue growth, revenue CAGR, and revenue share each segment is expected to register over the forecast period.

Product & Service Type Outlook (Revenue, USD Million; 2020-2028)

·         Quality Control Products

·         Whole Blood-based Controls

·         Serum/Plasma-based Controls

·         Urine-based Controls

·         Data Management Solutions

·         Quality Assurance Services

·         Source-based IVD Quality Controls

Manufacturer Outlook (Revenue, USD Million; 2020-2028)

·         Third-Party Control Manufacturers

·         Original Equipment Manufacturers (OEMs)

·         Instrument-Specific Controls

·         Independent Controls

Application Outlook (Revenue, USD Million; 2020-2028)

·         Immunochemistry/Immunoassay

·         Coagulation & Hemostasis

·         Molecular Diagnostics

·         Clinical Chemistry

·         Microbiology

·         Hematology

·         Others

End-use Outlook (Revenue, USD Million; 2020-2028)

·         Hospitals

·         Home Care

·         Clinical Laboratories

·         Academic & Research Institutes

·         Contract Research Organizations (CROs)

·         IVD Manufacturers

·         Others

For a better understanding of the global In-Vitro Diagnostics (IVD) Quality Control  market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread across key geographical regions such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is analysed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market. It provides insights into production and consumption patterns, supply and demand ratio, export/import, current and emerging trends and demands, market share, market size, revenue contribution, and presence of key players in each region.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1508

In-depth regional analysis includes:

·         North America (U.S., Canada, Mexico)

·         Europe (Italy, U.K., Germany, France, Rest of EU)

·         Asia Pacific (India, China, Japan, South Korea, Australia, Rest of APAC)

·         Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)

·         Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-market

Benefits of the Global In-Vitro Diagnostics (IVD) Quality Control  Report:

·         Comprehensive analysis of the opportunities and risks of the In-Vitro Diagnostics (IVD) Quality Control  market

·         Detailed study of the latest product and technological developments and innovations of the In-Vitro Diagnostics (IVD) Quality Control  market

·         Business strategies and plans are analysed for understanding the In-Vitro Diagnostics (IVD) Quality Control  market scenario

·         Revenue forecast of In-Vitro Diagnostics (IVD) Quality Control  market for the forecast period 2020-2028

·         Comprehensive analysis of the drivers, constraints, limitations, challenges, and opportunities

·         Latest and emerging market trends analysis and their impact on product and application demand

·         Study of recent M&A, joint ventures, collaborations, partnerships, product launches and brand promotions among others

·         Extensive SWOT analysis and Porter’s Five Forces analysis along with investment return analysis and feasibility

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1508

Thank you for reading our report. Please get in touch with us to know more about the report and customization of the report. Our team will ensure the report is tailored to meet your requirements.  

Browse More Related Reports :

BCG Vaccine Market  Statistics

Targeted RNA Sequencing Market  Report

Testosterone Replacement Therapy Market  Companies

Vegetable (HPMC) Capsule Market  Research

Anti Glaucoma Eyedrops Market  Growth Rate

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

[elizasanchez]

Mice Model Market Demand, Trends, Share, Scope & Forecast To 2027

The global mice model market is anticipated to reach USD 2.00 Billion by 2027, according to a current analysis by Emergen Research. During the forecast period, the global mice model market is projected to expand substantially, due to the increasing demand for humanized mice prototypes. The increasing use of mice models in the study of virology and contagious diseases is anticipated to propel the global mice model market further during the forecast period. Furthermore, rising adoption of mice models for clinical research by contract research organizations (CROs) is projected to boost the global mice model market in the near future.

The latest report entails a comprehensive analysis of this particular business vertical while providing precise information related to the different industry segmentations. The report captures the essence of the market, offering details on its different valuations, present scenario, volume consumption, revenue share over the projected period. In addition, the report largely focuses on delivering information regarding the geographical outlook of the global Mice Model market, as well as the companies and organizations dominating the market.

To receive a sample copy of this report, visit @ https://www.emergenresearch.com/request-sample/457

The prominent players of the global Mice Model market are expected to contribute significantly to the revenue generation owing to increasing demand for the Mice Model products in the industry.

Prominent Players Profiled in the Mice Model Market:

Envigo Ltd, TransViragen Inc., Charles River Laboratories International Inc., GenOway S.A., The Jackson Laboratory, Ozgene Pty Ltd, GVK Biosciences Private Limited, Taconic Biosciences Inc., Pharmaron, Inc., and Horizon Discovery Group plc.

Key Highlights of Report

Due     to the growing usage of mice model in immunology disease research and     infectious disease experiments and also in monoclonal antibody production,     the inbred segment is anticipated to lead the market during the forecast     period 

Due     to growing use of mice model to produce personalized drugs and also for     drug development, the breeding segment is projected to hold the largest     market share and expand at a CAGR of 7.0% throughout the forecast period.     Furthermore, growing usage of mice model to recognize genotypes for     research purposes is projected to fuel the segment further during the     forecast period.

Due     to growing use of mice model for drug development and veterinary     testing purposes, the pharmaceutical segment is anticipated to lead the     market throughout the forecast period

During     the forecast period, the North America region is projected to lead the     global market, owing to presence of major market players and rise in     biomedical studies in this region

Mice Model Market Segmentation:

Emergen Research has segmented the global mice model market on the basis of type, service, technology, application, end-use, and region.

·         Type Outlook (Revenue, USD Billion; 2017–2027)

o    Outbred

o    Hybrid

o    Inbred

o    Knockout

o    Spontaneous Mutant

·         Service Outlook (Revenue, USD Billion; 2017–2027)

o    Cryopreservation

o    Rederivation

o    Genetic Testing

o    Breeding

o    Quarantine

o    Others

·         Technology Outlook (Revenue, USD Billion; 2017–2027)

o    CRISPR

o    Nuclear Transfer

o    Embryonic Stem Cell Injection

o    Microinjection

o    Others

·         Application Outlook (Revenue, USD Billion; 2017–2027)

o    Cancer

o    Diabetes

o    Research & Development

o    Academics

o    Cardiovascular Studies

o    Genetic Studies

o    Infectious Diseases

o    Neurological Diseases

o    Others

·         End-use Outlook (Revenue, USD Billion; 2017–2027)

o    Pharmaceutical

o    Cosmetics

o    Biotechnology

o    Government

o    Contract Research Organizations

o    Academic & Research Institutes

o    Others

The research study also offers insights into various regulatory frameworks and evaluates the growth of the industry in each key region of the world. The report also provides an assessment of the micro and macro-economic factors influencing the growth of the market in the mentioned regions. The global Mice Model market is segmented into the following based on the key regions of the world:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/457

Summary of the Global Mice Model Report:

·         Comprehensive analysis of the market including risks and opportunities

·         Details of business strategies and plans undertaken by key market players

·         Analysis of current and future trends that will affect the growth of the market in the forecast timeline

·         In-depth analysis of drivers and constraints for better understanding of the market

·         The report encompasses a detailed forecast for the years 2020-2027.

·         The report provides valuable insights on key market growth driving trends and monetary competence in the forecast timeline.

Table of Content:

Chapter 1. Methodology & Sources     1.1. Market Definition     1.2. Research Scope      1.3. Methodology     1.4. Research Sources           1.4.1. Primary           1.4.2. Secondary           1.4.3. Paid Sources     1.5. Market Estimation Technique Chapter 2. Executive Summary     2.1. Summary Snapshot, 2019-2027 Chapter 3. Key Insights Chapter 4. Mice Model Market Segmentation & Impact Analysis     4.1. Mice Model Market Segmentation Analysis     4.2. Industrial Outlook           4.2.1. Market indicators analysis           4.2.2. Market drivers analysis                     4.2.2.1. Increasing demand of humanized mice prototypes                     4.2.2.2. The increasing use of models of mice in virology and contagious diseases                     4.2.2.3. Increasing investment in research and development activities in the pharmaceutical & biotechnology sector                     4.2.2.4. The increasing utilization of mice model for personalized drugs production           4.2.3. Market restraints analysis                     4.2.3.1. Continuous discovery in substitute approaches for animal studies                     4.2.3.2. Rising objections by many organizations against mouse testing     4.3. Technological Insights     4.4. Regulatory Framework     4.5. Porter’s Five Forces Analysis     4.6. Competitive Metric Space Analysis     4.7. Price trend Analysis     4.8. Covid-19 Impact Analysis

READ MORE…!

For further details on this report, click here @ https://www.emergenresearch.com/industry-report/mice-model-market

Thank you for reading our report. Customization of the report is available according to the requirements of clients. Do get in touch with us to know more about the report. Our team will ensure the report is tailored according to your needs.

Have a Look at Related Reports:

Autoinjectors Market@ https://www.emergenresearch.com/industry-report/autoinjectors-market

Blockchain Supply Chain Market@ https://www.emergenresearch.com/industry-report/blockchain-supply-chain-market

Non-Volatile Memory Express (NVMe) Market@ https://www.emergenresearch.com/industry-report/non-volatile-memory-express-market

IoT in Education Market@ https://www.emergenresearch.com/industry-report/iot-in-education-market

Hemodynamic Monitoring Devices Market@ https://www.emergenresearch.com/industry-report/hemodynamic-monitoring-devices-market

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

[adityarana1687-blog]

Medical Writing Market Worth To Excel USD 7.7 Billion By 2027

The global medical writing market size is expected to reach USD 7.7 billion by 2027, expanding at a CAGR of 10.9% during the forecast period, based on a new report by Grand View Research, Inc. Market growth can be attributed to increasing R&D investments by pharmaceutical companies, rise in contract research organization (CRO) outsourcing, partnerships & collaborations between market players, surge in the number of clinical trials, and updates in medical device regulations.

The European MEDDEV 2.7/1 Rev.4 guidance on Clinical Evaluation Reports (CER) was published in 2016. As per a recent article published in 2018, regulations, such as European Medical Devices Regulation (MDR 2017/745) and In-Vitro Diagnostics Regulation (IVDR 2017/746) followed in May 2017, and key changes relevant to writers in the field of medicine include increased need for relevant data from clinical studies and requirement of experienced authors. Such stringent regulations are expected to positively impact the medical writing market growth.

Drug development is a billion dollar industry with complex processes of obtaining product approvals. A well-documented, well-communicated, and well-developed research is needed to gain product approval, which increases the demand for experienced writers in the field of medicine. In addition, social media has become a crucial part of marketing and communication strategies of many organizations, including healthcare providers. Social networking is now being used in order to engage with patients as part of digital marketing, thereby creating high demand for writing services in the field of medicine.

Strategic alliances between large pharma companies and CROs have become an ongoing trend. Around 20 major partnerships have been finalized in the last five years. For instance, in October 2016, Quintiles and IMS Health underwent the biggest merger in the CRO industry and reestablished the weightage of both the companies. The merger helped Quintiles to use IMS’ internal database in order to design targeted and complex clinical trials.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/medical-writing-market

Further key findings from the study suggest:

By type, the clinical writing segment dominated the market 2019 due to increase in clinical trials. The regulatory writing segment is expected to witness the fastest growth over the forecast period owing to requirement of submission of regulatory documents to the authorities

On the basis of application, medical journalism dominated the market in 2019 and is expected to maintain its lead over the forecast period. Medico marketing is projected to witness the fastest growth over the forecast period

Medical writing has become essential in the field of education as specialized knowledge and skill is required to write well-structured and lucid scientific documents, thus driving the medical education application segment

Based on the end use, the CROs & others accounted for the largest market share in 2019 and is expected to exhibit the fastest CAGR over the forecast period

In 2019, North America dominated the global medical writing market due to increasing number of drug trials and approval of new drugs

Asia Pacific is expected to expand at the fastest CAGR over the forecast period owing to availability of cheap labor, abundance of resources, and presence of English writers

Some of the key players operating in the market are IQVIA; Parexel International Corp.; Trilogy Writing & Consulting GmBH; Covance, Inc.; OMICS International; and Freyr e, Inc.; OMICS International; and Freyr

Grand View Research has segmented the global medical writing market based on type, application, end use, and region:

Medical Writing Type Outlook (Revenue, USD Million, 2016 - 2027)

Clinical Writing

Regulatory Writing

Scientific Writing

Others

Medical Writing Application Outlook (Revenue, USD Million, 2016 - 2027)

Medical Journalism

Medical Education

Medico Marketing

Others

Medical Writing End-use Outlook (Revenue, USD Million, 2016 - 2027)

Medical Devices/Pharma & Biotechnological Companies

Contract Research Organizations (CROs) & Others

Medical Writing Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

U.K.

Germany

France

Italy

Spain

Japan

China

India

Brazil

Mexico

Argentina

South Africa

United Arab Emirates (UAE)

Saudi Arabia

Iran

Turkey

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

[marketreportsupdates]

Bioreactors and Fermenters Market Global Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2028

Rising prevalence of chronic diseases and favourable government initiatives to improve healthcare infrastructure are the key factors driving industry growth  

The global bioreactors and fermenters market size is expected to reach USD 5.17 Billion by 2028 at a CAGR of 10.7% through the forecast period, according to the latest report by Reports and Data. Increasing popularity of single-use bioreactor among biopharmaceutical companies to cultivate biologics is the key factor expected to drive market revenue growth over the forecast period.

Bioreactors and fermentors are culture systems to produce organisms or cells. They are used in various applications, including the manufacturing of biopharmaceuticals, basic research & development, chemicals, food & food additives, and other products. Cultivating cells and microbes in bioreactors can save work, time, and lab-space. It also improves the reproducibility and efficiency of cell growth and product formation.

Increasing focus of biologics manufacturers to scale-up production technologies for biologics is expected to stimulate global bioreactors and fermenters market trends. Moreover, surging demand for personalized medicines coupled with rising number of FDA approved orphan drugs has led to increased bio production, which in turn is expected to offer major opportunities for the industry growth in the coming years.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/285

Some Key Highlights in the Report:

·         Based on type, the single-use bioreactors segment is expected to account for largest revenue share over the forecast period. The robust growth can be attributed to various benefits associated with single-use bioreactors, including easy set up for continuous processing and ease of use as compared to stainless steel bioreactors. Single-use bioreactors reduce maintenance costs save space as they do not require the same utility and piping infrastructure as traditional stainless-steel bioreactors.

·         Based on application, the biopharmaceutical companies segment is expected to contribute significantly to the global bioreactors and fermenters market revenue share over the forecast period. Increasing usage of bioreactors and fermenters for cultivating a broad range of cell types and organisms, including cells (like mammalian insect cells, stem cells, cell lines), plant cells & algae, microorganisms (like bacteria, fungi, yeasts), and others.

·         The contract manufacturing organization (CMOs) segment is estimated to observe notable growth during the forecast period on account of growing outsourcing needs for biologics manufacturers as a result of increased demand of biologics.

·         In the regional landscape, North America accounted for the largest revenue share in bioreactors and fermenters market in 2020 and is expected to register rapid revenue CAGR over the forecast period. Market growth is driven by growth in number of bio manufacturing facilities and investments in this region. Moreover, active support of the regional governments to boost biologics production by providing funds to life science R&D will also contribute to revenue growth of the market over the forecast period.

·         Key players operating in the global bioreactors and fermenters market include Sartorius AG BBI, GE Healthcare, Praj Hipurity Systems, Danaher (Pall), ZETA, Thermo Fisher, Pierre Guerin (DCI-Biolafitte), Bioengineering AG, Merck KGaA, Solaris, Applikon Biotechnology, Eppendorf AG, and Infors HT among others. Rising investments by the key industry players for the R&D activities will bolster market growth over the analysis period.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/285

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2028. For the purpose of this study, Reports and Data has segmented the global bioreactors and fermenters market on the basis of type, application and region:

Type Outlook (Revenue, USD Billion; 2018-2028)

Single-use Bioreactors

Multiple-use Bioreactors

Application Outlook (Revenue, USD Billion; 2018-2028)

Biopharmaceutical Companies

CROs

Academic and Research Institutes

Others

Regional Outlook (Revenue, USD Billion; 2018-2028)

 U.S.

 Canada

 Mexico

 U.K.

 France

 Germany

 Spain

 Italy

 BENELUX

 Rest of Europe

 China

 India

 Japan

 South Korea

 Rest of APAC

 Brazil

 LATAM

 Saudi Arabia

 U.A.E.

 South Africa

 Rest of MEA

In conclusion, the report offers a comprehensive analysis of the factors expected to drive the global Bioreactors and Fermenters market growth over the forecast period of 2021-2028. The report is an all-inclusive document covering the market landscape and a futuristic perspective on its growth and progress. The report also provides an analysis of the entry-level driving and restraining factors for the new entrants contributing to the market. The report also offers strategic recommendations to the established players as well as new entrants to help them gain a strong foothold in the market.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/285

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Read More Reports:-

Allergy Immunotherapy Market @ https://www.google.no/url?q=https://www.reportsanddata.com/report-detail/allergy-immunotherapy-market

Sterilization Equipment Market @ https://www.google.by/url?q=https://www.reportsanddata.com/report-detail/global-sterilization-equipment-market

Nanomedicine Market @ https://www.google.kz/url?q=https://www.reportsanddata.com/report-detail/nanomedicine-market

[marketresearchstrategy]

In vivo CRO Industry Supply Chain Analysis, Growth Opportunities, Top Companies, Revenue Growth and Business Development Report by 2027

The global in vivo CRO market size reached USD 3.61 Billion in 2020 and is expected to reach USD 6.44 Billion in 2028 and register a CAGR of 8.6% over the forecast period, according to latest analysis by Reports and Data. The in vivo CRO market revenue growth is fueled by various factors including increasing demand for the CROs (Contract Research Organization) in pharmaceutical drug development, rising price competition among companies, and growing requirement to reduce cost combined with rising demand for advanced products. Additionally, changing regulatory policies in several organizations, and increasing chronic medical conditions are some of the factors also expected to contribute to the revenue growth of the global in vivo CRO market during the forecast period. Furthermore, the in vivo CRO market revenue growth is increasing at a significant extent, as drug manufacturers increases their pipeline products in order to develop as well as manufacture new molecule to sustain in the market with good profit, and with a patent product.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1634

The report initially offers market introduction, market overview, product scope, market opportunities, growth prospects, risks, limitations, and key drivers. The report also covers a comprehensive analysis of the competitive landscape with extensive profiling of the key competitors. It covers recent technological advancements, product developments, product launches, mergers and acquisitions, collaborations, joint ventures, and partnerships.

Key Companies in the market include:

American Preclinical Services, LLC, BTS Research, Charles River Laboratories, Chiltern International Ltd., Crown Bioscience, Eurofins Scientific, Evotec, ICON PLC, INC Research, inVentiv Health, Parexel International, Pharmaceutical Product Development, LLC (PPD), PRA Health Sciences, Quintiles, Taconic Biosciences and Theorem Clinical Re

Regional segmentation comprises of a current and forecast estimation of the market in the key geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report also covers the scope of individual applications and types in each region. The report also covers details about production and consumption patterns, technological developments, revenue growth, market size, market share, key trends and demands influencing market growth in the region, and robust presence of key players in the region.

Market segment analysis:

Type Outlook (Revenue: USD Billion; 2017-2027)

Rats

Mice

Others

Hamsters

Guinea Pigs

Others

GLP Type Outlook (Revenue: USD Billion; 2017-2027)

In House

Outsourcing

In House

Outsourcing

Indication Outlook (Revenue: USD Billion; 2017-2027)

Rheumatoid Arthritis

Multiple Sclerosis

Osteoarthritis

Irritable Bowel Syndrome

Others

Chronic Pain

Acute Pain

Blood Cancer

Solid Tumor

Syngeneic Model

Patient Derived Xenograft

Xenograft

Others

Epilepsy

Parkinson’s Disease

Huntington’s Disease

Stroke

Traumatic Brain Injury

ALS

Muscle Regeneration

Others

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/1634

Regional analysis further covers a country-wise analysis to offer insights into key trends and demands in each major country that might affect the growth of the market in the region.

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

Mexico

Germany

U.K.

Italy

France

BENELUX

Rest of Europe

China

India

Japan

South Korea

Rest of APAC

Brazil

Rest of LATAM

Saudi Arabia

A.E.

South Africa

Rest of MEA

To know more about the report @ https://www.reportsanddata.com/report-detail/in-vivo-cro-market

Key Features of the Global In vivo CRO Market Report:

Comprehensive analysis of the key players operating in the market along with their SWOT analysis, their business profiles, business overview, market share, global position, and market value

Identification and analysis of significant trends and factors driving revenue growth of the market

Analysis of the competitive landscape along with strategic mergers, expansions, agreements, partnerships, joint ventures, acquisitions, and product launches

Assessment of each market segment along with their growth trends and market revenue contribution

Study of the key regions to pinpoint growth potential and study opportunities, threats, limitations, and risks

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/1634

Thank you for reading our report. Customization of this report is available according to the client’s needs. Please get in touch with us to know more about the customization feature and our team will ensure the report is tailored as per your requirements.

Browse more reports:

Hot Melt Adhesives Market Size

Off Highway Vehicle Engine Market Share

[deshpandeisha]

Exploring New Horizons: Clinical Trial Software

Clinical trial software refers to specialized computer programs and digital platforms designed to facilitate and optimize various aspects of the clinical trial process. These software solutions are tailored to the unique needs of researchers, clinicians, pharmaceutical companies, and other stakeholders involved in conducting clinical trials.

Clinical trial software Market Size – USD 900.3 Million in 2020, Market Growth – at a CAGR of 15.6%, Market Trends –Increasing focus on decentralized or virtual clinical trials

Request a Sample Report with Table of Contents and Figures to click Here: https://www.emergenresearch.com/request-sample/766

Competitive Terrain:

The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Clinical Trial Software market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.

The leading market contenders listed in the report are:

Medidata Solutions Inc., International Machine Business Corporation (IBM), Oracle Corporation, Parexel International Corp., RealTime Software Solutions LLC, BioClinica Inc., MasterControl Inc., MedNet Solutions Inc., Veeva Systems Inc., and ArisGlobal LLC

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/clinical-trial-software-market

Emergen Research has segmented the global Clinical Trial Software market on the basis of type, application, end-use, and region:

Segments Covered in this report are:

Deployment Outlook (Revenue, USD Million; 2018–2028)

On-Cloud

On-Premises

Delivery Outlook (Revenue, USD Million; 2018–2028)

Web-Based

Licensed Enterprise (On-Premise)

Software as a Service (SAAS)

End-use Outlook (Revenue, USD Million; 2018–2028)

Pharmaceutical & Biotechnology Companies

Contract Research Organizations (CROs)

Medical Device Manufacturers

Others

The various regions analyzed in the report include:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Objectives of the Report:

Analysis and estimation of the Clinical Trial Software Market size and share for the projected period of 2022-2028

Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape

Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Clinical Trial Software Market

Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments

Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/766

[shital1998]

Biopharmaceutical Processing Equipment and Consumables Market - Global Opportunity Analysis and Industry Forecast (2022-2029)

Meticulous Research®– leading global market research company published a research report titled “Biopharmaceutical Processing Equipment and Consumables Market by Product Type {Filtration, Chromatography [Columns, Equipment], Disposable Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D), and End User- Forecast to 2029.”

According to this latest publication from Meticulous Research, the global biopharmaceutical processing equipment and consumables market is expected to grow at a CAGR of 10.3% to reach $70.84 billion by 2029. Initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical manufacturing plants, and growing use of single-use technologies in commercial bioproduction are the factors driving the market growth.

Biopharmaceutical Processing Equipment and Consumables Market: Future Outlook

The global biopharmaceutical processing equipment and consumables market study presents, historical market data in terms of values (2020 and 2021), estimated current data (2022), and forecasts it for 2029 –by Product Type (Filtration Systems, Chromatography Systems {Resins, Columns, & Equipment}, Bioreactors {Reusable Bioreactors, Disposable/Single-use Bioreactors}, Cell Culture Products {Cell Culture Media [Cell Culture Media, by Physical Form–Dry Powder Media, Liquid Media], [Cell Culture Media, by Type–Off-the-Shelf Media, Custom Media], [Cell Culture Media Market, by Source-Chemically Defined Media, Natural Media], Reagents and Supplements, Cell and Cell Lines, Serum}, Mixing Systems, Bioprocessing Containers, Sterilizers, Centrifuges, Incubators, Shakers, Biosafety Cabinets, Other Consumables and Accessories, Services), Application (Commercial Bioproduction {Vaccine Manufacturing, mAb Production, Recombinant Protein Production, Cell and Gene Therapy Production}, Research and Development), End User (Biopharmaceutical/ Biotechnology Companies, Contract Development and Manufacturing Organizations and Contract Research Organizations (CDMOs/CROs), & Academics and Research Institutes), and GeographyThe study also evaluates industry competitors and analyzes their market share at global and regional levels.

Download Free Sample PDF Copy

Scope of the Report:

Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type

 Resins

 Columns

 Equipment

 Reusable      Bioreactors

 Disposable/Single-use      Bioreactors

   Dry Powder Media

   Liquid Media

     Off-the-Shelf Media

   Custom Media

     Chemically Defined Media

   Natural Media

  (Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors)

Global Biopharmaceutical Processing Equipment and Consumables Market, by Application

 Vaccine      Manufacturing

 mAb      Production

 Recombinant      Protein Production

 Cell      and Gene Therapy Production

Global Biopharmaceutical Processing Equipment and Consumables Market, by End User

Biopharmaceutical/     Biotechnology Companies

Contract     Development and Manufacturing Organizations and Contract Research     Organizations (CDMOs/CROs)

Academics     and Research Institutes

 Biopharmaceutical Processing Equipment and Consumables Market, by Geography

 U.S.

 Canada

 Germany

 U.K.

 France

 Italy

 Spain

 Switzerland

 Rest      of Europe (RoE)

 China

 Japan

 India

 Rest      of APAC (RoAPAC)

Speak to Our Analyst

Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2022. The technological developments in filtration technologies and accelerated developments of single-use filtration systems to meet the growing need for single-use bioprocessing systems are contributing to the largest market share.

Based on application, the market is segmented into commercial bioproduction and R&D. The commercial bioproduction segment is estimated to account for the largest share of the market in 2022, owing to the growing number of biopharmaceuticals in the clinical development and nearing patent expiry of biologics.

Based on end user, the biopharmaceutical/biotechnology companies segment is estimated to account for the largest share of the market in 2022. The largest revenue share is attributed to the growing demand for biopharmaceutical equipment for commercial bioproduction in biopharmaceutical/biotechnology companies.

Geographic Review:

This research report analyzes major geographies and provides comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and Middle East & Africa.

North America is estimated to command the largest share of the biopharmaceutical processing equipment and consumables market in 2022, followed by Europe and Asia-Pacific. The U.S. is estimated to be the largest shareholding market in North America in 2022. An increase in the biotechnology R&D expenditure, the emergence of infectious diseases, supportive initiatives for increasing adoption of biosimilars, and large number of biopharmaceutical companies are some of the major factors driving the demand for biopharmaceutical processing equipment and consumables in the country.

BUY NOW

Key Players

The key players operating in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).

Key questions answered in the report-

Which are     the high-growth market segments in terms of product type, application, end     user, and regions/countries?

What was     the historical market for biopharmaceutical processing equipment and     consumables across the globe?

What are     the market forecasts and estimates for the period 2022–2029?

What are     the major drivers, restraints, challenges, opportunities, and trends in     the global market of biopharmaceutical processing equipment and     consumables?

Who are     the major players in the global biopharmaceutical processing equipment and     consumables market?

How is     the competitive landscape, and who are the market leaders in the global     biopharmaceutical processing equipment and consumables market?

What are     the recent developments in the biopharmaceutical processing equipment and     consumables market?

What are     the different strategies adopted by the major players in the     biopharmaceutical processing equipment and consumables market?

What are     the geographical trends and high growth regions/countries?

Contact Us: Meticulous Research® Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Connect with us on Twitter- https://twitter.com/MeticulousR123

[jesse-pinkman123]

Animal Model Market Size, Share, Outlook, Trends, Forecast, Insights 2026

Animal Model Market, by Species Type (Rodents (Rats, Mouse, Guinea Pigs and Woodchuck), Rabbits, Monkeys, and Other Species), by Application (Toxicology Studies, Drug Discovery and Development, Basic and Applied Research, and Others), by End Users (Academic & Research Institutions, Contract Research Organizations (CROs), and Pharmaceutical companies), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2018 – 2026

Most of the biomedical researches are carried on animal model with short-term objective to study toxicity of drugs for developing new therapeutics for certain diseases. The main objective of using animal model in research is to determine how the animal will respond to the treatment. The anatomical and physiological similarities between humans and animals help the researchers to investigate novel therapies in animal models before applying it on humans. The use of animal model in research is based on fact that human diseases can affect other animal species. It is not only limited for infectious diseases but also for common diseased conditions including diabetes, hypertension, cancer, epilepsy, and others.

Animal Model Market Outlook

Increasing number of research based on animal test to develop novel drugs is a major factor that boosts the animal model market growth. For instance, as per data reported in Annual Statistics of Scientific Procedures on Living Animals, about 3.79 million scientific procedures were carried out on protected living animals in Great Britain in 2017.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2488

Moreover, as per data in Worldwide Animal Research Statistics, in 2016, 3,789,373 vertebrates per procedure and 110,553 mammals per procedure (excluding rats and mice) have been used in research experiments conducted in the U.S.

However, rising concern for animal welfare by social and government organizations leads to use lesser number of animals in research purpose, which may hamper growth of the animal model market.

Animal Model Market Regional Analysis

On the basis of region, the global animal model market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Geographically, North America is expected to witness conducive growth for animal model market, owing to high presence of major market players in this region. For instance, in September 2018, Taconic Biosciences, a U.S. based company providing genetically engineered rodent model solutions, announced partnership plans with Government Scientific Source (GSS) to become the first animal model provider on general services administration contract schedule. Taconic Bioscience’s products are fit into GSS effort to support biomedical research solutions within the U.S. federal government.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/animal-model-market-2488

Moreover, in November 2018, Jackson Laboratory, an independent, nonprofit biomedical research institution headquartered in Maine, the U.S., established a dedicated quarantine facility for the importation of JAX Mice into China. Thus, expansion of facilities by manufacturers in Asia Pacific is expected to show high growth of the market during the forecast period.

Increasing use of animal models in research for developing vaccines is another major factor, which will show significant growth for animal model market in Europe. For instance, in November 2018, in the workshop organized by EDUFLUVAC consortium, a European Union funded project, coordinated by the European Vaccine Initiative, experts from influenza vaccine community gathered to discuss the current knowledge and future perspectives for testing broadly reactive influenza vaccines in animal models. The workshop has been organized for summarizing the outcome of “Experimental animal models for universal influenza vaccines” project.

Key players in the animal model market include Charles River Laboratories International, Inc., Horizon Discovery Group plc, The Jackson Laboratory, Trans Genic Inc, Taconic Biosciences, Inc., Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc., Harbour Antibodies BV, Envigo CRS SA, Ingenious Targeting Laboratory, and Transposagen Biopharmaceuticals, Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2488

About Coherent Market Insights:            

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

[mrfrblogresearch02]

Drug Discovery Informatics Market Value Chain, Growth, Trends, Huge Business Opportunity 2027

Market Highlights

The global Drug Discovery Informatics Market Size held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% over the forecast period. Factors driving market growth include impending need to curtail drug discovery and development costs, focus on drug discovery, increasing expenditure on R&D, and large prevalence of chronic diseases. According to the WHO report of 2001, chronic diseases accounted for 60% of the deaths that year. Nearly 46.4% of the deaths in 2020 will be credited to chronic diseases triggering the market demand. But setup of laboratories and high costs of informatics software can restrict the market growth.

Drug discovery plays a vital role in the life sciences, pharmaceutical, and biopharmaceutical industries. The amount of data accumulated from clinical trials and tests is vast and requires software to sift through. New approaches in drug discovery informatics for accumulating and processing information can lead to faster commoditization of drugs, medicines, and vaccines. The global drug discovery informatics market report by Market Research Future (MRFR) contains a comprehensive overview followed by pertinent factors and drawbacks for the period

Regional Analysis

Europe, Asia Pacific (APAC), the Americas, and the Middle East & Africa (MEA) are regions covered in the global drug discovery informatics market report.

The Americas dominated the global market in 2017 due to presence of prominent names such as International Business Machines, PerkinElmer Inc., and ThermoFisher Scientific Inc. Establishment of next-generation sequencing and chemical laboratories in the U.S. and Canada, boom in pharmaceutical and biopharmaceutical industries, and sophisticated healthcare infrastructure.

Europe is the second largest region and highly lucrative for the global drug discovery informatics market till 2023. This can be credited to funding allocated to research and development on drug research by governments, growth in therapeutic discovery centers, and successful activities by research and academic institutes, universities, and other prestigious centers.

APAC can be ensured to display a profitable growth rate during the forecast period due to the large geriatric population, drug delivery system packaging factory and heavy prevalence of chronic diseases. Awareness of the software, adoption of the software in pharma and biopharma companies, and a rise in clinical studies can drive the regional market growth. Lower costs, lax policies and regulations, and a spurt in clinical trials are other factors making the region lucrative for the global drug discovery informatics market.

Drug Discovery Informatics Market Segmentation:

The global drug discovery informatics market has been segmented into product, mode, service, end user, and region.

By product, the market has been segmented into discovery informatics and development informatics.

On the basis of mode, the market has been divided into in-house informatics and outsourced informatics.

By service, the market has been classified into sequencing and target data analysis, docking, molecular modeling, clinical trial data management, and others. The sequencing and target data analysis segment is expected to dominate the market over the forecast period due to rising application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process.

Based on end user, the market has been categorized into pharmaceutical and biotechnology industries, contract research organizations (CROs), and others.

Drug Discovery Informatics Market Competitive Outlook

Few of the foremost players in the global drug discovery informatics market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Certara, L.P., Infosys Limited, Novo Informatics Pvt. Ltd., Collaborative Drug Discovery Inc., Selvita, Charles River Laboratories, Inc., International Business Machines Corporation, Jubilant Life Sciences Ltd., IO Informatics, Inc., GVK Biosciences Private Limited, and Dassault Systèmes.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com